glp-1 direct gip and glp 1 Potential Use of and GIP/GLP-1 Receptor Agonists for Users have emphasized realistic expectations GLP-1 Receptor Agonists as Treatments
Description
Physiol-endocm 298 (3), E634E643
Garg and team
The market is no longer just about diabetes, but a global metabolic shift with new players entering and new indications emerging
In: Basic & Clinical Pharmacology
[DOI] [PMC free article] [PubMed] [Google Scholar] 30.Marso S.P., Bain S.C., Consoli A., Eliaschewitz F.G., Jdar E., Leiter L.A., Lingvay I., Rosenstock J., Seufert J., Warren M.L., et al
Dos revisores (JLL y KDD), independientemente, revisaron y evaluaron ttulos y resmenes identificados en la bsqueda
